Page 61 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon

1522_C01.fm Page 48 Tuesday, December 2, 2003 10:05 AM

158. Taylor, E.H., Oertli, E.H., Wolfgang, J.W., and Mueller, E., Accuracy of five on-
site immunoassay drugs-of-abuse testing devices, J. Anal. Toxicol., 23, 119, 1999.
159. Iwersen-Bergmann, S. and Schmoldt, A., Direct semiquantitative screening
of drugs of abuse in serum and whole blood by means of CEDIA DAU urine
immunoassays, J. Anal. Toxicol., 23, 247, 1999.
160. Scholer, A., Nicht-instrumentelle Immunoassays in der Suchtmittelanalytik
(Drogenanalytik), Toxichem. Krimtech., 66, 27, 1999.
161. Lekskulchai, V. and Mokkhavesa, C., Evaluation of Roche Abuscreen ONLINE
amphetamine immunoassay for screening of new amphetamine analogues,
J. Anal. Toxicol., 25, 471, 2001.
162. Zhao, H., Brenneisen, R., Scholer, A., McNally, A.J., ElSohly, M.A., Murphy,
T.P., and Salamone, S.J., Profiles of urine samples taken from Ecstasy users
at Rave parties: analysis by immunoassays, HPLC, and GC-MS, J. Anal. Tox-
icol., 25, 258, 2001.
163. Wikstroem, M., Holmgren, P., and Ahlner, J., N-Benzylpiperazine, a “new”
drug of abuse in Sweden, in Rasanen, I., Ed., Abstract book, 38th Int. TIAFT
Meeting, Helsinki, 2000, 88.
164. Balmelli, C., Kupferschmidt, H., Rentsch, K., and Schneemann, M., Fatal
brain edema after ingestion of ecstasy and benzylpiperazine, Dtsch. Med.
Wochenschr, 126, 809, 2001.
165. de Boer, D., Bosman, I.J., Hidvegi, E., Manzoni, C., Benko, A.A., dos, R.L.,
and Maes, R.A., Piperazine-like compounds: a new group of designer drugs-
of-abuse on the European market, Forensic Sci. Int., 121, 47, 2001.
166. Staack, R.F., Fritschi, G., and Maurer, H.H., GC-MS studies on the metabo-
lism and on the toxicological analysis of the new piperazine-like designer
drugs BZP, MDBP, TFMPP, mCPP, MeOPP, in Proceedings of the 39th Inter-
national TIAFT Meeting in Prague, 2001, Balikova, M. and Navakova, E., Eds.,
Charles University, Prague, 2002, 115.
167. Staack, R.F., Fritschi, G., and Maurer, H.H., Studies on the metabolism and
the toxicological analysis of the new piperazine-like designer drugs BZP and
TFMPP using GC-MS, in Proceedings of the XIIth GTFCh Symposium in
Mosbach, Pragst, F. and Aderjan, R., Eds., Helm-Verlag, Heppenheim, Ger-
many, 2001, 149.
168. Shulgin, A., #142 PEA; Phenethylamine, in Pihkal, A Chemical Love Story,
Dan Joy, Ed., Transform Press, Berkley, CA, 1991, 815.
169. Bye, C., Munro, F.A., Peck, A.W., and Young, P.A., A comparison of the effects
of 1-benzylpiperazine and dexamphetamine on human performance tests,
Eur. J. Clin. Pharmacol., 6, 163, 1973.
170. Tekes, K., Tothfalusi, L., Malomvolgyi, B., Herman, F., and Magyar, K., Studies
on the biochemical mode of action of EGYT-475, a new antidepressant, Pol.
J. Pharmacol. Pharm., 39, 203, 1987.

© 2004 by CRC Press LLC